The Pathogenic Role of AIP Mutations - The Importance of the Integration of Clinical, Experimental and Modeling Data on Advising Patients and Their Families with Pituitary Adenoma Predisposition.
Päätekijät: | Trivellin, G, Bolger, G, Igreja, S, Chahal, H, Grossman, AB, Korbonits, M |
---|---|
Aineistotyyppi: | Conference item |
Julkaistu: |
2010
|
Samankaltaisia teoksia
-
Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.
Tekijä: Igreja, S, et al.
Julkaistu: (2010) -
AIP mutation in pituitary adenomas in the 18th century and today.
Tekijä: Chahal, H, et al.
Julkaistu: (2011) -
Brief Report: AIP Mutation in Pituitary Adenomas in the 18th Century and Today.
Tekijä: Chahal, H, et al.
Julkaistu: (2011) -
Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.
Tekijä: Chahal, H, et al.
Julkaistu: (2012) -
Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort.
Tekijä: Preda, V, et al.
Julkaistu: (2014)